OBJECTIVE: Manganese (Mn), an established neurotoxicant, is a common component of welding fume. The neurological phenotype associated with welding exposures has not been well described. Prior epidemiologic evidence linking occupational welding to parkinsonism is mixed, and remains controversial. METHODS: This was a cross-sectional and nested case-control study to investigate the prevalence and phenotype of parkinsonism among 811 shipyard and fabrication welders recruited from trade unions. Two reference groups included 59 non-welder trade workers and 118 newly diagnosed, untreated idiopathic PD patients. Study subjects were examined by a movement disorders specialist using the Unified Parkinson Disease Rating Scale motor subsection 3 (UPDRS3). Parkinsonism cases were defined as welders with UPDRS3 score ≥15. Normal was defined as UPDRS3<6. Exposure was classified as intensity adjusted, cumulative years of welding. Adjusted prevalence ratios for parkinsonism were calculated in relation to quartiles of welding years. RESULTS: The overall prevalence estimate of parkinsonism was 15.6% in welding exposed workers compared to 0% in the reference group. Among welders, we observed a U-shaped dose-response relation between weighted welding exposure-years and parkinsonism. UPDRS3 scores for most domains were similar between welders and newly diagnosed idiopathic Parkinson disease (PD) patients, except for greater frequency of rest tremor and asymmetry in PD patients. CONCLUSION: This work-site based study among welders demonstrates a high prevalence of parkinsonism compared to nonwelding-exposed workers and a clinical phenotype that overlaps substantially with PD.
OBJECTIVE:Manganese (Mn), an established neurotoxicant, is a common component of welding fume. The neurological phenotype associated with welding exposures has not been well described. Prior epidemiologic evidence linking occupational welding to parkinsonism is mixed, and remains controversial. METHODS: This was a cross-sectional and nested case-control study to investigate the prevalence and phenotype of parkinsonism among 811 shipyard and fabrication welders recruited from trade unions. Two reference groups included 59 non-welder trade workers and 118 newly diagnosed, untreated idiopathic PDpatients. Study subjects were examined by a movement disorders specialist using the Unified Parkinson Disease Rating Scale motor subsection 3 (UPDRS3). Parkinsonism cases were defined as welders with UPDRS3 score ≥15. Normal was defined as UPDRS3<6. Exposure was classified as intensity adjusted, cumulative years of welding. Adjusted prevalence ratios for parkinsonism were calculated in relation to quartiles of welding years. RESULTS: The overall prevalence estimate of parkinsonism was 15.6% in welding exposed workers compared to 0% in the reference group. Among welders, we observed a U-shaped dose-response relation between weighted welding exposure-years and parkinsonism. UPDRS3 scores for most domains were similar between welders and newly diagnosed idiopathic Parkinson disease (PD) patients, except for greater frequency of rest tremor and asymmetry in PDpatients. CONCLUSION: This work-site based study among welders demonstrates a high prevalence of parkinsonism compared to nonwelding-exposed workers and a clinical phenotype that overlaps substantially with PD.
Authors: Jonathan E Myers; Jim teWaterNaude; Markus Fourie; H B Abie Zogoe; Inakshi Naik; Penny Theodorou; Halina Tassel; Aarti Daya; Mary Lou Thompson Journal: Neurotoxicology Date: 2003-08 Impact factor: 4.294
Authors: Eun-Young Lee; Michael R Flynn; Guangwei Du; Mechelle M Lewis; Lan Kong; Jeff D Yanosky; Richard B Mailman; Xuemei Huang Journal: Toxicol Sci Date: 2019-04-01 Impact factor: 4.849
Authors: Eun-Young Lee; Michael R Flynn; Guangwei Du; Mechelle M Lewis; Rebecca Fry; Amy H Herring; Eric Van Buren; Scott Van Buren; Lisa Smeester; Lan Kong; Qing Yang; Richard B Mailman; Xuemei Huang Journal: Toxicol Sci Date: 2015-05-07 Impact factor: 4.849
Authors: Susan R Criswell; Susan Searles Nielsen; Mark N Warden; Hubert P Flores; Jason Lenox-Krug; Sophia Racette; Lianne Sheppard; Harvey Checkoway; Brad A Racette Journal: J Occup Environ Med Date: 2019-08 Impact factor: 2.162
Authors: Marissa G Baker; Yvonne S Lin; Christopher D Simpson; Laura M Shireman; Susan Searles Nielsen; Brad A Racette; Noah Seixas Journal: J Trace Elem Med Biol Date: 2018-11-03 Impact factor: 3.849
Authors: Susan R Criswell; Gill Nelson; Luis F Gonzalez-Cuyar; John Huang; Joshua S Shimony; Harvey Checkoway; Christopher D Simpson; Russell Dills; Noah S Seixas; Brad A Racette Journal: Neurotoxicology Date: 2015-04-23 Impact factor: 4.294
Authors: Mechelle M Lewis; Michael R Flynn; Eun-Young Lee; Scott Van Buren; Eric Van Buren; Guangwei Du; Rebecca C Fry; Amy H Herring; Lan Kong; Richard B Mailman; Xuemei Huang Journal: Neurotoxicology Date: 2016-08-24 Impact factor: 4.294
Authors: Marissa G Baker; Christopher D Simpson; Bert Stover; Lianne Sheppard; Harvey Checkoway; Brad A Racette; Noah S Seixas Journal: J Occup Environ Hyg Date: 2014 Impact factor: 2.155
Authors: Eun-Young Lee; Michael R Flynn; Guangwei Du; Mechelle M Lewis; Amy H Herring; Eric Van Buren; Scott Van Buren; Lan Kong; Richard B Mailman; Xuemei Huang Journal: Toxicol Sci Date: 2016-07-27 Impact factor: 4.849